Search

ResMed Inc

Закрыт

СекторЗдравоохранение

228.48 0.1

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

225

Макс.

229.51

Ключевые показатели

By Trading Economics

Доход

1.1B

1.5B

Продажи

32M

1.5B

P/E

Средняя по отрасли

21.38

56.432

Прибыль на акцию

2.95

Дивидендная доходность

1.1

Рентабельность продаж

104.075

Сотрудники

11,370

EBITDA

-91M

493M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+5.69% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

1.10%

2.27%

Следующий отчет о доходах

29 окт. 2026 г.

Дата следующей выплаты дивидендов

24 сент. 2026 г.

Следующая эксдивидендная дата

12 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

952M

32B

Предыдущая цена открытия

228.38

Предыдущая цена закрытия

228.48

Новостные настроения

By Acuity

13%

87%

12 / 339 Рейтинг в Healthcare

ResMed Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

17 сент. 2026 г., 19:46 UTC

Resmed Inc is trading modestly higher, peaking mid-afternoon before retracing slightly, and remains within its one-month price range.

16 сент. 2026 г., 21:31 UTC

ResMed Inc. is seeing a modest increase in after-hours trading, reaching a peak return of 0.46% following Wednesday's close.

15 сент. 2026 г., 22:02 UTC

Social Media

RBC Capital upgraded ResMed Inc to Outperform and raised its price target to $262, with shares trading roughly flat in after-market hours.

9 сент. 2026 г., 20:07 UTC

Resmed Inc. shares are lower today amid broader market declines and inflationary pressures tied to rising crude oil prices and interest rate hike speculation.

8 сент. 2026 г., 20:02 UTC

News

Resmed Inc shares are lower amid a broader decline in the Health Care Equipment sector, reflecting six consecutive sessions of lower closes.

4 сент. 2026 г., 19:47 UTC

Resmed Inc shares are lower, continuing a recent downward trend. No specific news explains today's price movement amid rising Treasury yields and unchanged unemployment figures.

3 сент. 2026 г., 22:16 UTC

Resmed Inc. remains roughly flat in after-market trading, with no specific news identified. The stock has faced recent pressure, finishing lower in the last three sessions.

2 сент. 2026 г., 20:08 UTC

Resmed Inc. shares are lower today, reflecting broader market declines since Tuesday. The ADP report indicates slower job growth, impacting Federal Reserve rate considerations.

1 сент. 2026 г., 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

31 авг. 2026 г., 20:07 UTC

ResMed Inc shares are lower today, influenced by Fed officials' comments on inflation and interest rates. Earlier, shares briefly recovered above Friday's close.

28 авг. 2026 г., 20:07 UTC

News

Resmed Inc shares are higher today, reaching a session high and exceeding their 20-day moving average amid rising U.S. Treasury yields and inflation concerns.

27 авг. 2026 г., 19:36 UTC

Social Media

Resmed Inc's shares are lower amid concerns over its MatrixCare divestiture, which reflects a significant drop in valuation from its 2018 acquisition.

26 авг. 2026 г., 20:07 UTC

Resmed Inc shares are lower today, influenced by a decline in the Health Care Equipment sub-sector. No specific company news was identified.

25 авг. 2026 г., 23:36 UTC

Shares of Resmed Inc. rose in after-market trading, continuing an upward trend since Tuesday's close despite earlier declines. The stock remains above its 20-day moving average.

24 авг. 2026 г., 23:56 UTC

Resmed Inc. shares are lower in after-market hours amid weak trading sentiment. No specific company news was identified to explain the decline.

21 авг. 2026 г., 20:06 UTC

ResMed Inc shares are higher today, reflecting broader market trends. The stock remains above its 20-day moving average and near its one-month range.

20 авг. 2026 г., 20:06 UTC

Shares of Resmed Inc. are lower amid rising crude oil prices and increasing U.S. Treasury yields, reflecting broader market trends. No specific company news was identified.

19 авг. 2026 г., 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18 авг. 2026 г., 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17 авг. 2026 г., 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14 авг. 2026 г., 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13 авг. 2026 г., 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12 авг. 2026 г., 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11 авг. 2026 г., 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 авг. 2026 г., 20:02 UTC

Social Media
News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 авг. 2026 г., 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 авг. 2026 г., 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 авг. 2026 г., 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 авг. 2026 г., 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 авг. 2026 г., 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

Сравнение c конкурентами

Изменение цены

ResMed Inc Прогноз

Целевая цена

By TipRanks

5.69% рост

Прогноз на 12 месяцев

Средняя 241.417 USD  5.69%

Максимум 320 USD

Минимум 213 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для ResMed Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

15 ratings

5

Покупка

10

Удержание

0

Продажа

Настроения

By Acuity

12 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat